Pathophysiology and Neuroimmune Interactions Underlying Parkinson's Disease and Traumatic Brain Injury
- PMID: 37108349
- PMCID: PMC10138999
- DOI: 10.3390/ijms24087186
Pathophysiology and Neuroimmune Interactions Underlying Parkinson's Disease and Traumatic Brain Injury
Abstract
Parkinson's disease (PD) is a progressive neurodegenerative disorder clinically defined by motor instability, bradykinesia, and resting tremors. The clinical symptomatology is seen alongside pathologic changes, most notably the loss of dopaminergic neurons in the substantia nigra pars compacta (SNpc) and the accumulation of α-synuclein and neuromelanin aggregates throughout numerous neural circuits. Traumatic brain injury (TBI) has been implicated as a risk factor for developing various neurodegenerative diseases, with the most compelling argument for the development of PD. Dopaminergic abnormalities, the accumulation of α-synuclein, and disruptions in neural homeostatic mechanisms, including but not limited to the release of pro-inflammatory mediators and the production of reactive oxygen species (ROS), are all present following TBI and are closely related to the pathologic changes seen in PD. Neuronal iron accumulation is discernable in degenerative and injured brain states, as is aquaporin-4 (APQ4). APQ4 is an essential mediator of synaptic plasticity in PD and regulates edematous states in the brain after TBI. Whether the cellular and parenchymal changes seen post-TBI directly cause neurodegenerative diseases such as PD is a point of considerable interest and debate; this review explores the vast array of neuroimmunological interactions and subsequent analogous changes that occur in TBI and PD. There is significant interest in exploring the validity of the relationship between TBI and PD, which is a focus of this review.
Keywords: Parkinson’s disease; S100A9; S100B; TBI; microglia; neurodegeneration; neuroinflammation; neuromelanin; oxidative stress; α-synuclein.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Alpha-synuclein as a pathological link between chronic traumatic brain injury and Parkinson's disease.J Cell Physiol. 2015 May;230(5):1024-32. doi: 10.1002/jcp.24830. J Cell Physiol. 2015. PMID: 25251017 Free PMC article.
-
Lasting Impact: Exploring the Brain Mechanisms that Link Traumatic Brain Injury to Parkinson's Disease.Mol Neurobiol. 2025 Jun;62(6):7421-7444. doi: 10.1007/s12035-025-04706-x. Epub 2025 Feb 1. Mol Neurobiol. 2025. PMID: 39891816 Free PMC article. Review.
-
Biological links between traumatic brain injury and Parkinson's disease.Acta Neuropathol Commun. 2020 Apr 7;8(1):45. doi: 10.1186/s40478-020-00924-7. Acta Neuropathol Commun. 2020. PMID: 32264976 Free PMC article. Review.
-
Adolescent mice exposed to TBI developed PD-like pathology in middle age.Transl Psychiatry. 2025 Jan 25;15(1):27. doi: 10.1038/s41398-025-03232-7. Transl Psychiatry. 2025. PMID: 39863574 Free PMC article.
-
T cell infiltration and upregulation of MHCII in microglia leads to accelerated neuronal loss in an α-synuclein rat model of Parkinson's disease.J Neuroinflammation. 2020 Aug 15;17(1):242. doi: 10.1186/s12974-020-01911-4. J Neuroinflammation. 2020. PMID: 32799878 Free PMC article.
Cited by
-
Feasibility Study of Parkinson's Speech Disorder Evaluation With Pre-Trained Deep Learning Model for Speech-to-Text Analysis.Korean J Neurotrauma. 2024 Sep 23;20(3):168-179. doi: 10.13004/kjnt.2024.20.e30. eCollection 2024 Sep. Korean J Neurotrauma. 2024. PMID: 39372118 Free PMC article.
-
Next-Generation Drug Delivery for Neurotherapeutics: The Promise of Stimuli-Triggered Nanocarriers.Biomedicines. 2025 Jun 13;13(6):1464. doi: 10.3390/biomedicines13061464. Biomedicines. 2025. PMID: 40564183 Free PMC article. Review.
-
GPX3 as a Novel and Potential Therapeutic Target in the Shared Molecular Mechanisms of Traumatic Brain Injury and Parkinson's Disease.J Inflamm Res. 2025 Feb 7;18:1911-1928. doi: 10.2147/JIR.S506891. eCollection 2025. J Inflamm Res. 2025. PMID: 39935526 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous